Rethinking neoadjuvant chemotherapy for breast cancer

    loading  Checking for direct PDF access through Ovid

Abstract

As evidence questioning the rationale behind neoadjuvant chemotherapy in breast cancer grows, Jayant Vaidya and colleagues say we must reconsider the current treatment options

Related Topics

    loading  Loading Related Articles